1. Medtech Insight
  2. >>Business

Stanford Launches Trial Of NeuroPace’s Responsive Neuromodulation To Stop Overeating

 
• By Reed Miller

The DBSLOC trial will study the feasibility of using NeuroPace’s RNS responsive neuromodulation system to stimulate the nucleus accumbens in order to stop “loss-of-control” eating in people with treatment-refractory obesity, especially those who have failed to respond adequately to gastric bypass surgery.

Brain Processor of a Human Mind and Memory Concept 3d Illustration Render - Illustration
• Source: shutterstock.com

Researchers at Stanford University’s Halpern-Malenka lab are trying to adapt NeuroPace’s RNS System, a closed-loop neuromodulation implant currently approved to treat epilepsy, to treat obesity.

Casey Halpern, a neurosurgeon at Stanford University is leading DBSBLOC, a six-patient, single-site, early feasibility study to support development of NeuroPace’s RNS System for nucleus accumbens-responsive neurostimulation to ameliorate...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D